Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Griffin Noreen, Executive. Insider active across 1 company, notably Immune Therapeutics, Inc.. Aggregated, 1 filings have been logged. Activity tracked since 28 May 2021. The latest transaction was filed on 28 May 2021 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Noreen Griffin is associated with Immune Therapeutics, Inc. Although her specific role is not detailed, she contributes to the leadership of the company in the biotechnology field. Her expertise is essential for the development and implementation of the company's strategies.